MarkNtel Advisors recently published a detailed industry analysis of the Global Cardiac Ablation Devices Market. The report covers growth trends, geographical marketing strategies, challenges, opportunities, and drivers influencing the market.

Global Cardiac Ablation Devices Market, Share, and Trends Analysis Report – Industry Overview and Forecast to 2027

The Cardiac Ablation Devices Market is projected to grow at a CAGR of around 16.53% during the forecast period, i.e., 2022-27.

What are the major Driver the Global Cardiac Ablation Devices industry?

Surging Incidences of Atrial Fibrillation Worldwide- Atrial Fibrillation (AF) has been a common type of arrhythmia in which the heart beats rapidly or slowly. It can either result in strokes or heart failure and happens mainly due to excessive intake of alcohol & caffeine, sedentary lifestyle, smoking, consumption of dietary supplements, etc. Due to this, heart diseases, high blood pressure, chronic heart diseases, thyroid, obesity, etc., have increased substantially. AF often coexists with heart failure as well as obesity in the aging population.

Moreover, the prevalence of AF is higher among people aged 65 & above. The escalating geriatric population in both developed & developing countries like the US, Japan, countries of Western Europe, and India & China are expected to propel the incidence rate of AF in the coming years.

As a result, it would accelerate the demand for cardiac ablation devices over the forecast years. Japan, China, etc., are amongst the most impacted countries by AFib in 2022. With the continuous growth in the aging population in Japan, an estimated 1 million patients are expected to have AFib by 2030, as reported by the European Society of Cardiology.

Besides, the steady rise in AFib-related hospital admissions, mounting inclination toward cardiac ablation for AFib treatment, and investments made by several companies in this sector to maximize their revenue are other crucial aspects anticipated to drive the market during 2022-27.

• In 2021, Boston Scientific acquired Farapulse for USD 295 million to expand its market share of cardiac Ablation devices. The company had been an investor of 27% in Farapulse since 2014, but the recent acquisition would provide 100% ownership to Boston Scientific.

✅In case you missed it, we are currently revising our reports. Click on the below to get the latest research data with forecast for years 2025 to 2030, including market size, industry trends, and competitive analysis. It wouldn’t take long for the team to deliver the most recent version of the report.

Access the detailed PDF Sample report –  https://www.marknteladvisors.com/query/request-sample/cardiac-ablation-devices-market.html

What segments define the Global Cardiac Ablation Devices Market from 2022 to 2027? How do these segments contribute to market dynamics and growth?

By Product

• Water-cooled radiofrequency ablation
• Temperature-Controlled Radiofrequency Ablators
• Tissue Contact Probes
• Microwave Thermotherapy Devices
• Others (Robotic Catheter Manipulation Systems, Ultrasound Ablation Systems, etc.)

According to report, Based on the Product, a Temperature-controlled radiofrequency ablator is projected to grab significant market share in the global cardiac ablation device market.

By Technology

• Radiofrequency (RF) Ablation
• Cryoablation Device
• Laser Ablation
• Electrical Ablators
• Microwave Ablation
• Ultrasound Ablation

According to report, Here, Cryoablation Devices acquired a considerable market share during 2017-20, and the same trend is anticipated to prevail over the forecast years. 

By Application

• Cardiac Rhythm Management
• Tachycardia
• Atrial Fibrillation and Flutter
• Open Surgery

According to report, Atrial Fibrillation and flutter witnessing astronomical growth in the global market as it is among the most common heart rhythm disorder among the geriatric population, owing to which the risk of heart failure and stroke has increased substantially.

By End-Users

• In-patient
• Outpatient

According to report, Of both, In-patients held the highest share in the Global Cardiac Ablation Device Market in 2021, primarily due to the surging incidences of cardiovascular diseases among the elderly population worldwide, coupled with the increasing number of hospitalizations due to AFib.

Explore the Complete Global Cardiac Ablation Devices Market Analysis Report – https://www.marknteladvisors.com/research-library/cardiac-ablation-devices-market.html

Geographical Analysis: Global Cardiac Ablation Devices Market

By Region

• North America
• South America
• Europe
• Asia-Pacific
• Rest of World

Global Cardiac Ablation Devices Market Share & Competitive Landscape:

The Cardiac Ablation Devices Market is characterized by intense competition, with several key players driving growth through innovation, market expansion, and strategic investments. The competitive landscape provides valuable insights into the industry's leading companies, highlighting their strengths, financial performance, and market influence.

Leading Companies in the Global Cardiac Ablation Devices Market are:

• Abbott Laboratories
• Medtronic plc
• Olympus Corporation
• Johnson & Johnson (Biosense Webster, Inc.)
• Boston Scientific Corporation
• CONMED Corporation
• AngioDynamics, Inc.
• CardioFocus Inc.
• Stryker Corporation
• MicroPort Inc.
• Stereotaxis Inc.
• Teleflex Incorporated
• Lepu Medical Technology
• Avanos Medical
• AtriCure
• Others

Global Cardiac Ablation Devices Industry Recent Development:

• In 2022, Medtronic acquired Affera Inc. to expand its cardiac ablation portfolio. Affera designs & manufactures electrophysiology (EP) cardiac mapping & navigation systems and catheter-based cardiac ablation technologies. The company aims to establish its footprint in the cardiac ablation space.

• In 2020, Biosense Webster launched CARTO 3 System Version 7 and the CARTO PRIME mapping module to advance the treatment of complex arrhythmias. CARTO PRIME is powered with improvised mapping capabilities that help significantly reduce ablation times compared to standard mapping algorithms.

• In 2020, Boston Scientific Corporation acquired Farapulse, Inc., a privately-held company developing a pulsed-field ablation (PFA) system for the treatment of atrial fibrillation (AF) and other cardiac arrhythmias.

Questions Addressed in this Study

1.What factors are driving the Global Cardiac Ablation Devices Market growth?

2.How is the Global Cardiac Ablation Devices Market expected to grow over the next five years?

3.What are the key insights into the current trends in the Global Cardiac Ablation Devices Market?

4.What is the current size of the Global Cardiac Ablation Devices Market, and how is it projected to change in the future?

6.What is the future outlook for the Global Cardiac Ablation Devices Market in terms of technological advancements and market expansion?

For a Customized Analysis Report, Just Drop Your Inquiry Here – https://www.marknteladvisors.com/query/request-customization/cardiac-ablation-devices-market.html

Why MarkNtel Advisors?

MarkNtel Advisors is a leading research, consulting, & data analytics firm that provides an extensive range of strategic reports on diverse industry verticals. We deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, & individuals, among others.

Our specialization in niche industries informed way and entail parameters like Go-to-Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing & forecasting, & trend analysis, among others, for 15 diverse industrial verticals.

More Research Studies Report:

-Biocomposites Market size was valued at around USD 36.9 billion in 2024 and is projected to reach USD 89 billion by 2030 with a CAGR of around 16%.

-Green Solvents Market size was valued at around USD 1.34 billion in 2024 & is projected to reach USD 1.87 billion by 2030 with a CAGR of around 5.7%.

For Media Inquiries, Please Contact:

Email: [email protected]

Sales Office: 564 Prospect St, B9, New Haven, Connecticut, USA-06511

Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India